EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

Kasper A Overbeek, Jakob L Poulsen, Marco Lanzillotta, Olof Vinge-Holmquist, Peter Macinga, A Fatih Demirci, Daniko P Sindhunata, Johanna Backhus, Hana Algül, Jorie Buijs, Philippe Levy, Mariia Kiriukova und 48 weitere

Clinical Gastroenterology and Hepatology · 2024-05 · 22 (5) · 994-1004.e10

DOI: 10.1016/j.cgh.2023.12.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-05. Verfasst von Kasper A Overbeek und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: k.overbeek@erasmu…. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Autoimmune pancreatitis (AIP) is an immune-mediated disease of the pancreas with distinct pathophysiology and manifestations. Our aims were to characterize type 1 AIP in a large pan-European cohort and study the effectiveness of current treatment regimens. METHODS: We retrospectively analyzed adults diagnosed since 2005 with type 1 or not-otherwise-specified AIP in 42 European university hospitals. Type 1 AIP was uniformly diagnosed using specific diagnostic criteria. Patients with type 2 AIP and those who had undergone pancreatic surgery were excluded. The primary end point was complete remission, defined as the absence of clinical symptoms and resolution of the index radiologic pancreatic abnormalities attributed to AIP. RESULTS: We included 735 individuals with AIP (69% male; median age, 57 years; 85% White). Steroid treatment was started in 634 patients, of whom 9 (1%) were lost to follow-up. The remaining 625 had a 79% (496/625) complete, 18% (111/625) partial, and 97% (607/625) cumulative remission rate, whereas 3% (18/625) did not achieve remission. No treatment was given in 95 patients, who had a 61% complete (58/95), 19% partial (18/95), and 80% cumulative (76/95) spontaneous remission rate. Higher (≥0.4 mg/kg/day) corticosteroid doses were no more effective than lower ( 2 weeks (odds ratio, 0.908; 95% confidence interval, 0.818-1.009). Elevated IgG4 levels were independently associated with a decreased chance of complete remission (odds ratio, 0.639; 95% confidence interval, 0.427-0.955). Relapse occurred in 30% of patients. Relapses within 6 months of remission induction were independent of the steroid-tapering duration, induction treatment duration, and total cumulative dose. CONCLUSIONS: Patients with type 1 AIP and elevated IgG4 level may need closer monitoring. For remission induction, a starting dose of 0.4 mg/kg/day for 2 weeks followed by a short taper period seems effective. This study provides no evidence to support more aggressive regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune PancreatitisHumansMaleMiddle AgedFemaleRetrospective StudiesEuropeAgedTreatment OutcomeAdultSteroidsAged, 80 and over

Stichwörter der Autor:innen

Autoimmune PancreatitisIgG4-Related DiseaseIgG4-Related Pancreatitis

Substanzen

Steroids

Autor:innen und Institutionen

  • Department of Gastroenterology & Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: k.overbeek@erasmusmc.nl.
  • Centre for Pancreatic Diseases, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy.
  • Department of Digestive Surgery, Akershus University Hospital, Loerenskog, Norway; Department of Digestive Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Internal Medicine, Marmara University Research and Education Hospital, Istanbul, Turkey.

Zitieren

APA

Overbeek, K. A., Poulsen, J. L., Lanzillotta, M., Vinge-Holmquist, O., Macinga, P., Demirci, A. F., Sindhunata, D. P., Backhus, J., Algül, H., Buijs, J., Levy, P., Kiriukova, M., Goni, E., Hollenbach, M., Miksch, R. C., Kunovsky, L., Vujasinovic, M., Nikolic, S., Dickerson, L., …, & Olesen, S. S. (2024). Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Clinical Gastroenterology and Hepatology, 22(5), 994-1004.e10. https://doi.org/10.1016/j.cgh.2023.12.010

Vancouver

Overbeek KA, Poulsen JL, Lanzillotta M, Vinge-Holmquist O, Macinga P, Demirci AF, et al. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Clinical Gastroenterology and Hepatology. 2024;22(5):994-1004.e10. doi:10.1016/j.cgh.2023.12.010

BibTeX
@article{Overbeek2024,
  author = {Overbeek, Kasper A and Poulsen, Jakob L and Lanzillotta, Marco and Vinge-Holmquist, Olof and Macinga, Peter and Demirci, A Fatih and Sindhunata, Daniko P and Backhus, Johanna and Algül, Hana and Buijs, Jorie and Levy, Philippe and Kiriukova, Mariia and Goni, Elisabetta and Hollenbach, Marcus and Miksch, Rainer C and Kunovsky, Lumir and Vujasinovic, Miroslav and Nikolic, Sara and Dickerson, Luke and Hirth, Michael and Neurath, Markus F and Zumblick, Malte and Vila, Josephine and Jalal, Mustafa and Beyer, Georg and Frost, Fabian and Carrara, Silvia and Kala, Zdenek and Jabandziev, Petr and Sisman, Gurhan and Akyuz, Filiz and Capurso, Gabriele and Falconi, Massimo and Arlt, Alexander and Vleggaar, Frank P and Barresi, Luca and Greenhalf, Bill and Czakó, László and Hegyi, Peter and Hopper, Andrew and Nayar, Manu K and Gress, Thomas M and Vitali, Francesco and Schneider, Alexander and Halloran, Chris M and Trna, Jan and Okhlobystin, Alexey V and Dagna, Lorenzo and Cahen, Djuna L and Bordin, Dmitry and Rebours, Vinciane and Mayerle, Julia and Kahraman, Alisan and Rasch, Sebastian and Culver, Emma and Kleger, Alexander and Martínez-Moneo, Emma and Røkke, Ola and Hucl, Tomas and Olesen, Søren S},
  title = {Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {5},
  pages = {994--1004.e10},
  doi = {10.1016/j.cgh.2023.12.010}
}
Kostenlos starten →